Literature DB >> 29433724

Early Lung Cancer Detection.

Terunaga Inage1, Takahiro Nakajima1, Ichiro Yoshino1, Kazuhiro Yasufuku2.   

Abstract

Lung cancer is the most common cause of cancer deaths worldwide. A major reason for poor prognosis is that patients are usually diagnosed at an advanced stage and thus there are limited options for curative treatment at the time of diagnosis. Early detection may improve lung cancer survival, as demonstrated in computed tomography screening studies. New and innovative bronchoscopic methods have been developed for the early diagnosis of lung cancer. High-precision bronchoscopic imaging technology, such as optical biopsy, may potentially replace traditional biopsy techniques. This article reviews the advanced technologies for detection of early lung cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autofluorescence bronchoscopy; Carcinoma in situ; Early detection; Endocytoscopy; High magnification bronchovideoscope; Lung cancer; Narrow band imaging; Sputum cytology

Mesh:

Year:  2017        PMID: 29433724     DOI: 10.1016/j.ccm.2017.10.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  18 in total

1.  MiR-449b-5p targets lncRNA PSMG3-AS1 to suppress cancer cell proliferation in lung adenocarcinoma.

Authors:  Na Yue; Ming Ye; Ran Zhang; Yunquan Guo
Journal:  BMC Pulm Med       Date:  2020-05-29       Impact factor: 3.317

2.  Long noncoding RNA CBR3 antisense RNA 1 promotes the aggressive phenotypes of non‑small‑cell lung cancer by sponging microRNA‑509‑3p and competitively upregulating HDAC9 expression.

Authors:  Yun Guan; Juan Yang; Xinmei Liu; Lijuan Chu
Journal:  Oncol Rep       Date:  2020-08-07       Impact factor: 3.906

3.  LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis.

Authors:  Wen Sun; Liwen Zhang; Ranran Yan; Ying Yang; Xiangli Meng
Journal:  Onco Targets Ther       Date:  2019-05-22       Impact factor: 4.147

4.  The value of Cone-Beam CT-guided radiofrequency ablation in the treatment of pulmonary malignancies (≤3 cm).

Authors:  Zi-Jun Xiang; Yi Wang; En-Fu Du; Lin Xu; Bin Jiang; Huili Li; Yun Wang; Ning Cui
Journal:  Biosci Rep       Date:  2019-02-26       Impact factor: 3.840

5.  Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.

Authors:  Yang Li; Xudong Tian; Lei Gao; Xiaohong Jiang; Rao Fu; Tingting Zhang; Tianying Ren; Ping Hu; Yaping Wu; Peige Zhao; Dawei Yang
Journal:  Cancer Med       Date:  2019-05-27       Impact factor: 4.452

6.  Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.

Authors:  Stephen G Spiro; Pallav L Shah; Robert C Rintoul; Jeremy George; Samuel Janes; Matthew Callister; Marco Novelli; Penny Shaw; Gabrijela Kocjan; Chris Griffiths; Mary Falzon; Richard Booton; Nicholas Magee; Michael Peake; Paul Dhillon; Kishore Sridharan; Andrew G Nicholson; Simon Padley; Magali N Taylor; Asia Ahmed; Jack Allen; Yenting Ngai; Nyasha Chinyanganya; Victoria Ashford-Turner; Sarah Lewis; Dahmane Oukrif; Pamela Rabbitts; Nicholas Counsell; Allan Hackshaw
Journal:  Eur Respir J       Date:  2019-10-17       Impact factor: 16.671

7.  Silibinin suppresses epithelial-mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1.

Authors:  Suyan Xu; Hongyan Zhang; Aifeng Wang; Yongcheng Ma; Yuan Gan; Guofeng Li
Journal:  Cell Mol Biol Lett       Date:  2020-06-09       Impact factor: 5.787

Review 8.  Early diagnosis of lung cancer: which is the optimal choice?

Authors:  Jing Ning; Tao Ge; Minlin Jiang; Keyi Jia; Lei Wang; Wei Li; Bin Chen; Yu Liu; Hao Wang; Sha Zhao; Yayi He
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

9.  Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer.

Authors:  Xiaohong Xie; Liqiang Wang; Xinni Wang; Wan-Hung Fan; Yinyin Qin; Xinqing Lin; Zhanhong Xie; Ming Liu; Ming Ouyang; Shiyue Li; Chengzhi Zhou
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

10.  Long Noncoding RNA SNHG6 Functions as an Oncogene in Non-Small Cell Lung Cancer via Modulating ETS1 Signaling.

Authors:  Hua Geng; Shixiong Li; Meilin Xu
Journal:  Onco Targets Ther       Date:  2020-01-30       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.